Business Wire

Chart Streams in cTrader by Spotware: Broadcast Your Technical Analysis 24/7

6.3.2023 10:00:00 EET | Business Wire | Press release

Share

cTrader Web presents Chart Streams, allowing users to broadcast their technical analysis 24/7 by sending a simple link to their audience. Users can watch a Chart Stream in guest mode even if they are not registered in cTrader yet.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230305005002/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Chart Streams in cTrader (Photo: Spotware)

Use Chart Streams as an Educational Tool

For trading educators and strategy providers, this means the opportunity to grow their follower base by showcasing their skills. Also, their audience gets to benefit from a more detailed technical analysis education and the formation of stronger ties with their mentors. Watchers see the Chart Stream inside the live platform interface with total immersion into the trading process. They can also copy the chart with technical analysis from the Stream, open and edit it in a new window.

Start a Chart Stream

  1. Open the cTrader Web app
  2. Click the broadcast icon in a chart header
  3. Write a title and start your Stream
  4. Copy link and share with your audience

The Stream provider doesn’t need to be online all the time. The Stream will continue even if he closes the browser and switches off his laptop. So the Stream is available at any time for anyone who has the link. To end your Stream, click the “Stop” button or just close the chart window.

Spotware’s Head of Product, Alexander Strelnikov, says, “The Chart Streams feature is a major one for both professional educators and mentors, as well as their audiences. The ability to monitor a chart 24/7, seeing every update and indicator addition live, goes a long way towards improving one's own understanding of technical analysis, and helps create stronger trust bonds between mentors and followers. This way, it’s a win-win: professional traders and strategy providers grow their follower bases, while followers gain a new format of trading education. We are confident that the addition of this feature will prove to be a valuable part of the cTrader Web experience for all our users.”

Check out the Chart Stream from cTrader here .

About Spotware and cTrader

cTrader, a premium trading platform offered by leading brokers and trusted by millions of traders worldwide, is the flagship product of Spotware. cTrader is a one-of-a-kind platform that doesn’t engage in trader fraud and prides itself on 100% transparency while providing brokers with a complete solution that raises their brand value by putting them in a category of brokers that can be trusted while simultaneously catering to the needs of all their traders.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Svetlana Krysanova
+357 25 344 901
skrysanova@spotware.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Incyte Announces FDA Approval of Jakafi XR™ (ruxolitinib) Extended-Release Tablets for the Treatment of Myelofibrosis, Polycythemia Vera and Graft-Versus-Host Disease2.5.2026 00:28:00 EEST | Press release

Incyte (Nasdaq:INCY) today announced that the U.S. Food and Drug Administration (FDA) has approved Jakafi XR™ (ruxolitinib) extended-release tablets for the treatment of adults with intermediate- or high-risk myelofibrosis (MF); adults with polycythemia vera (PV) who have had an inadequate response to or are intolerant of hydroxyurea; as well as adults and children aged 12 years and older with steroid-refractory acute graft-versus-host disease (GVHD) or chronic GVHD after failure of one or two lines of systemic therapy. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260501334677/en/ “The approval of Jakafi XR reinforces Incyte’s leadership in hematology and our focus on meeting the evolving needs of patients with myeloproliferative neoplasms (MPNs) and GVHD,” said Bill Meury, Chief Executive Officer, Incyte. “Jakafi XR offers appropriate patients and physicians a once-daily option, expanding choice without changing the well-

Barilla Hosts Surprise Formula 1® Family Reunion Dinner During Miami Race Weekend1.5.2026 19:08:00 EEST | Press release

A special invitation, a table, and a plate of pasta shared by people who are often apart. That’s all it took for Barilla to bring the spirit of togetherness to Miami during the opening day of the FORMULA 1® CRYPTO.COM MIAMI GRAND PRIX 2026. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260430832316/en/ Barilla hosts Arvid Lindblad, Mikaela Shiffrin, and Nico Rosberg with Chef Massimo Bottura at Torno Subito, where the Formula 1® community came together for a surprise dinner. Barilla, the Official Pasta Partner of Formula 1®, welcomed team members and their families to Torno Subito Miami, the restaurant by three-Michelin-starred Chef Massimo Bottura, with the kitchen led by Chef Bernardo Paladini, for an evening where engines were switched off and everyday life took center stage. The night also celebrated the start of the new partnership between Barilla and the Visa Cash App Racing Bulls (VCARB) Formula 1® Team, a meeting of

TIME Names Xenco Medical one of the TIME100 Most Influential Companies in the World and the Winner of the 2026 TIME100 Impact Award in Health1.5.2026 13:07:00 EEST | Press release

Time Magazine has named pioneering medical technology company Xenco Medical as one of the TIME100 Most Influential Companies in the World and the Winner of the 2026 TIME100 Impact Award in Health. Widely regarded as the most prestigious recognition in business and technology, being selected to the TIME100 List remains the most coveted accolade that a company can achieve globally. The TIME100 Impact Awards are given to only 5 recipients each year, making it the rarest of honors that a company can receive and a profound recognition of transformative, global impact. Xenco Medical was honored by Time as the sole recipient of the TIME100 Impact Award in Health in 2026, signifying its leading, global distinction in impact on healthcare. According to Time Magazine, the TIME100 Most Influential Companies list highlights “companies making an extraordinary impact around the world.” The honor bestowed by Time comes after Xenco Medical was named the 2025 Medical Device/ Diagnostics Company of the

Inspirit Capital Completes Acquisition of Kaplan Languages Group1.5.2026 02:17:00 EEST | Press release

Inspirit Capital, a specialist investor in corporate carve-outs, and Kaplan, the global education company, have announced the completion of Inspirit’s acquisition of Kaplan Languages Group (KLG) from Kaplan. Financial terms are not being disclosed. KLG, a leading global language education platform, comprises Kaplan International Languages, Alpadia Language Schools, Azurlingua, and ESL Education. Inspirit Capital will support KLG in delivering on its ambitious growth plans, whilst continuing its fundamental mission to transform lives through language education. The next phase of ownership will see the development and launch of a refreshed standalone brand identity for KLG, with further announcements to follow on this in due course. KLG will continue to use the Kaplan name under a transitional license from Kaplan, Inc. until a new brand is announced. About Kaplan Languages Group Since 2006, KLG has provided the highest quality language education and cultural immersion experiences. Kaplan

Grindr Nominates Three New Directors to Its Board of Directors1.5.2026 00:16:00 EEST | Press release

Grindr Inc. (NYSE: GRND), the Global Gayborhood in Your Pocket™, today announced the nomination of Rob Solomon, Lisa Gersh, and Fadi Hanna to stand for election to its Board of Directors at the Annual Meeting of Shareholders on June 2, 2026. Rob Solomon is a deeply seasoned technology CEO and operator in consumer internet and marketplaces. He has held CEO and COO roles at scaled platforms including GoFundMe, Groupon, and Kayak-predecessor SideStep, and is currently CEO of leading electric aviation company H55. Lisa Gersh is a CEO and long-tenured public company director with deep experience across consumer brands, media, and commerce. She has served on the Hasbro (NASDAQ: HAS) board since 2010 and has led businesses including Oxygen Media, GOOP, and Alexander Wang. Fadi Hanna is Chief Risk Officer at Bloomberg L.P., overseeing enterprise risk across the organization. He previously worked at J.P. Morgan and has served on the board of Immigration Equality. “Over the last few years, we bu

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye